|
|
Blood, 1 October 2006, Vol. 108, No. 7, pp. 2455-2462.
Prepublished online as a Blood First Edition Paper on June 13, 2006; DOI 10.1182/blood-2006-04-017251.
Previous Article | Next Article 
Submitted April 14, 2006
Accepted May 13, 2006
Soluble CD40 ligand accumulates in stored blood
components, primes neutrophils through CD40, and is a
potential cofactor in the development of
transfusion-related acute lung injury
Samina Yasmin Khan, Marguerite R Kelher, Joanna M Heal, Neil Blumberg, Lynn K Boshkov, Richard Phipps, Kelly F Gettings, Nathan J McLaughlin, and Christopher C Silliman*
Department of Surgery, University of Colorado School of Medicine, Denver, CO
Transfusion Med, Hematology-Oncology, Environmental Med, Immunology & Lung Biol.,
Pathology, Oregon Health Sciences University, Portland, OR
Department of Pediatrics, University of Colorado School of Medicine, Denver, CO
Bonfils Blood Center, Denver, CODepartment of Pediatrics, University of Colorado School of Medicine,
* Corresponding author; email: christopher.silliman{at}uchsc.edu.
TRALI is a post-transfusion acute pulmonary insufficiency,
which has been linked to the infusion of biological
response modifiers (BRMs) including anti-leukocyte
antibodies and lipids. Soluble CD40 ligand (sCD40L) is a
platelet-derived pro-inflammatory mediator that
accumulates during platelet storage. We hypothesize that
human PMNs express CD40, CD40 ligation rapidly primes
PMNs, and sCD40L induces PMN- mediated cytotoxicity of
human pulmonary microvascular endothelial cells (HMVECs).
Levels of sCD40L were measured in blood components and in
platelet concentrates (PCs) implicated in TRALI or control
PCs that did not elicit a transfusion reaction. All blood
components contained higher levels of sCD40L than fresh
plasma with apheresis PCs evidencing the highest
concentration of sCD40L followed by PCs from whole blood,
whole blood, and PRBCs. PCs implicated in TRALI reactions
contained significantly higher sCD40L levels as compared
to control PCs. PMNs express functional CD40 on the plasma
membrane and recombinant sCD40L [10 ng/ml-1 ; µg/ml]
rapidly (5 min) primed the PMN oxidase. Soluble CD40L
promoted PMN-mediated cytotoxicity of HMVECs as the second
event in a two-event in vitro model of TRALI. We conclude
that sCD40L, which accumulates during blood component
storage, has the capacity to activate adherent PMNs
causing endothelial damage and may cause TRALI in
predisposed patients.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Hot on the trail of TRALI
- David F. Stroncek
Blood 2006 108: 2136-2137.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
P. C. Eckels, A. Banerjee, E. E. Moore, N. J. D. McLaughlin, L. M. Gries, M. R. Kelher, K. M. England, F. Gamboni-Robertson, S. Y. Khan, and C. C. Silliman
Amantadine inhibits platelet-activating factor induced clathrin-mediated endocytosis in human neutrophils
Am J Physiol Cell Physiol,
October 1, 2009;
297(4):
C886 - C897.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Phipps and N. Blumberg
Statin Islands and PPAR Ligands in Platelets
Arterioscler Thromb Vasc Biol,
May 1, 2009;
29(5):
620 - 621.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Triulzi
Transfusion-Related Acute Lung Injury: Current Concepts for the Clinician
Anesth. Analg.,
March 1, 2009;
108(3):
770 - 776.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Kelher, T. Masuno, E. E. Moore, S. Damle, X. Meng, Y. Song, X. Liang, J. Niedzinski, S. S. Geier, S. Y. Khan, et al.
Plasma from stored packed red blood cells and MHC class I antibodies causes acute lung injury in a 2-event in vivo rat model
Blood,
February 26, 2009;
113(9):
2079 - 2087.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Cognasse, J. M. Payrat, L. Corash, J. C. Osselaer, and O. Garraud
Platelet components associated with acute transfusion reactions: the role of platelet-derived soluble CD40 ligand
Blood,
December 1, 2008;
112(12):
4779 - 4780.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. D. Elzey, S. A. Crist, D. L. Sprague, and T. L. Ratliff
Response: Are PDMVs the biologically active source of CD154 in ATR?
Blood,
December 1, 2008;
112(12):
4780 - 4781.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Jawa, S. Anillo, and M. N. Kulaylat
Transfusion-Related Acute Lung Injury
J Intensive Care Med,
March 1, 2008;
23(2):
109 - 121.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Beauvillain, Y. Delneste, M. Scotet, A. Peres, H. Gascan, P. Guermonprez, V. Barnaba, and P. Jeannin
Neutrophils efficiently cross-prime naive T cells in vivo
Blood,
October 15, 2007;
110(8):
2965 - 2973.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Cholette, J. S. Rubenstein, G. M. Alfieris, M. P. McDermott, W. G. Harmon, R. Vermilion, M. P. Eaton, J. J. Gangemi, and N. B. Lerner
Elevated Risk of Thrombosis in Neonates Undergoing Initial Palliative Cardiac Surgery
Ann. Thorac. Surg.,
October 1, 2007;
84(4):
1320 - 1325.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Silliman, B. R. Curtis, P. M. Kopko, S. Y. Khan, M. R. Kelher, R. M. Schuller, B. Sannoh, and D. R. Ambruso
Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model
Blood,
February 15, 2007;
109(4):
1752 - 1755.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|